5Toshiaki Sugiura,Katsuhiko Iwakiri,Makoto Kotoyori,Masafumi Kobayashi. Relationship between severity of reflux esophagitis according to the Los Angeles classification and esophageal motility[J] 2001,Journal of Gastroenterology(4):226～230
6Dr. Michio Hongo MD,Shuichi Ohara MD,Yorihisa Hirasawa MD,Shinichiro Abe MD,Shigeru Asaki MD,Takayoshi Toyota MD. Effect of lansoprazole on intragastric pH[J] 1992,Digestive Diseases and Sciences(6):882～890
2Bruley des Varannes S, Shi G, Scarpignato C, et al. Sensitivity to acid and distension in gastro-oesophageal refluc disease(GORD) and the acid hypersensitive oesophagus. Gut, 1996, 39 (Suppl 3):A182.?A
3Villanacci V, Grigolato PG, Cestari R, et al. Dilated intercellular spaces as markers of reflux disease: histology, semiquantitative score and morphometry upon light microscopy. Digestion, 2001, 64:1-8.?A
4Johnsson F, Hatlebakk JG, Klintenberg AC, et al. Symptom-relieving effect of esomeprazole 40mg daily in patients with heartburn.Scand J Gastroenterol, 2003, 38:347-353.?A
5Numans ME, Lau J, Wit NJ, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease. Ann Intern Med, 2004, 140:518-527.?A
6Fock KM, Talley N, Hunt R, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol, 2004, 19:357-367.?A
7van Pinxteren B, Numans ME, Bonis PA, et al. Short term treatment with proton pump inhibitor, H2 receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and enddoscopy negative reflux disease. Cochrane Library 2003; 4. Available from URL: http:/www. cochrane. org/cochrane/revabstr/ab002095. htm?A.
8Quigley EM. Factors that influence therapeutic outcome in symptomatic gastroesophageal reflux disease. Am J Gastroenterol, 2003, 98(Suppl 3):S24-S30.?A
9Kahrilas PJ, Quigley EM, Castell DO, et al. The effects of tegaserod (HTF 919) on oesophgeal acid exposure in gastro-oesophageal reflux disease. Aliment Pharmacol Ther, 2000, 14:1503-1509.?A
10Lind T, Havelund T, Lundell L, et al. On demand therapy with omeprazole for the long term management of patients with heartburn without oesophagitis-a placebo-controlled randomized trial. Aliment Pharmacol Ther, 1999, 13:907-914.?A
